Effect of synthetic agonists of toll-like receptor 9 on canine lymphocyte proliferation and cytokine production in vitro. (original) (raw)

Im Hof, Michelle; Williamson, Lina; Summerfield, Artur; Balmer, Vreni; Dutoit, Virginie; Kandimalla, Ekambar R; Yu, Dong; Zurbriggen, Andreas; Doherr, Marcus; Peel, John; Roosje, Petra (2008). Effect of synthetic agonists of toll-like receptor 9 on canine lymphocyte proliferation and cytokine production in vitro. Veterinary immunology and immunopathology, 124(1-2), pp. 120-131. Elsevier10.1016/j.vetimm.2008.03.002

Full text not available from this repository.

Synthetic agonists of TLR9 containing novel DNA structures and R'pG (wherein R=1-(2'-deoxy-beta-d-ribofuranosyl)-2-oxo-7-deaza-8-methyl-purine) motifs, referred to as immune modulatory oligonucleotides (IMOs), have been shown to stimulate T(H)-1-type-immune responses and potently reverse allergen-induced T(H)-2 responses to T(H)-1 responses in vitro and in vivo in mice. In order to investigate the immunomodulatory potential of IMOs in dogs, canine peripheral blood mononuclear cells (PBMC) from healthy dogs were stimulated with three different IMOs and a control IMO, alone or in combination with concanavalin A (ConA). Lipopolysaccharide (LPS) was used as a positive control for B lymphocyte activation. Carboxyfluorescein diacetate succinimidyl ester and phenotype staining was used to tag proliferating T and B lymphocytes (CD5(+) and CD21(+)) by flow cytometry. Real-time PCR and ELISA were processed to assay cytokine production of IFN-gamma, IL-10, TGF-beta, IL-6 and IL-10. Like LPS, IMOs alone induced neither proliferation of CD5(+) T cells nor CD21(+) B cells, but both LPS and IMO had the capacity to co-stimulate ConA and induced proliferation of B cells. In combination with ConA, one of the IMOs (IMO1) also induced proliferation of T cells. IMO1 also significantly enhanced the expression of IFN-gamma on the mRNA and protein level in canine PBMC, whereas expression of IL-10, TGF-beta and IL-4 mRNAs was not induced by any of the IMOs. These results indicate that in canine PBMC from healthy dogs, IMO1 was able to induce a T(H)-1 immune response including T- and B-cell proliferation.

Interest & Impact

Downloads

0 since deposited on 10 Oct 2014
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

in Google Scholarâ„¢

Services

Actions (login required)

Edit item Edit item
Item Type: Journal Article (Original Article)
Division/Institute: 05 Veterinary Medicine > Department of Clinical Veterinary Medicine (DKV) > Small Animal Clinic > Small Animal Clinic, Internal Medicine05 Veterinary Medicine > Department of Clinical Veterinary Medicine (DKV) > Small Animal Clinic05 Veterinary Medicine > Department of Clinical Research and Veterinary Public Health (DCR-VPH) > Veterinary Public Health Institute05 Veterinary Medicine > Department of Clinical Research and Veterinary Public Health (DCR-VPH) > Experimental Clinical Research05 Veterinary Medicine > Department of Infectious Diseases and Pathobiology (DIP) > Institute of Virology and Immunology05 Veterinary Medicine > Department of Clinical Veterinary Medicine (DKV) > DKV - Dermatology
UniBE Contributor: Im Hof, Michelle, Summerfield, Artur, Balmer, Verena, Zurbriggen, Andreas (A), Doherr, Marcus, Roosje Hasler, Pieternella
Subjects: 600 Technology > 610 Medicine & health
ISSN: 0165-2427
Publisher: Elsevier
Language: English
Submitter: Simone Schuller
Date Deposited: 10 Oct 2014 11:02
Last Modified: 29 Mar 2023 23:34
Publisher DOI: 10.1016/j.vetimm.2008.03.002
PubMed ID: 18452997
URI: https://boris.unibe.ch/id/eprint/59168

Actions (login required)

Edit item Edit item